We use cookies for a better user experience. Read our Privacy Policy

I Agree

Pharma 4.0 Market

Pharma 4.0 Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031

Pharma 4.0 Market: Introduction

Pharma 4.0 is a framework for upgrade in the pharmaceutical industry to incorporate latest technological advancements to enhance the productivity and distribution network.

The four major developmental evolutionary stages of manufacturing have led to Pharma 4.0. Basically, Pharma 4.0 is an advanced operating model for pharmaceutical factories and supply chains, which is based on Industry 4.0 capabilities, digital advancement or digital maturity, and data integrity by design.

The first evolution stage involved implementation of steam power to mechanization. The second stage involved mass production, introduction of the assembly line which is powered by electricity. Third stage involved computers and automation into mixture and the fourth is the introduction of cyber-physical systems using computerization of manufacturing.

Pharma 4.0 primarily focuses on advanced technology, productivity, work force, integration, and quality control. It is nourished by developments in data, upgrade interconnectivity, collaborative robotics, artificial intelligence and cloud based architectures. Digitization is a change across the globe along with the value chain network. This virtual value chain counted on seamless and uninterrupted real-time data exchange and not on paper within less time.

Key Drivers and Restrains of Pharma 4.0 Market

  • The latest digitization trends, vast rise in Internet penetration as various industries are focusing on technological advancements for efficiency in cost and productivity drive the market. Demand for monitoring devices with pro technology for the proper diagnosis and treatment on some chronic diseases such as cardiac disorders is high.
  • Advance digital technologies such as Artificial Intelligence, IoT, 3D printing, block chain, and virtual & augmented reality augment the market by reducing the time and efforts of healthcare providers through the remote monitoring of patients, tracking of patients, and improvement in medical services and products. It includes product design, supply chain, manufacturing processes, customer service, and experience.
  • Increase in the number of hospitals and clinical centers that need rapid detection and technological support are propelling the market.
  • During the Covid-19 pandemic, the world realized the importance of technology and digitization. Industries, including pharmaceutical, are adapting digitization rapidly. Various regions across the globe are adapting telemedicine and online pharmacy services. Moreover, currently, large number of patients prefer personalized medicines.
  • In this 4.0 evolution, several companies are complaining about high cost of implementation, primarily in IT-based solutions, and the lack of skilled workforce or expertise, and the time and cost need for training. This is restraining the market.

North America to Capture Major Market Share

In terms of region, the global Pharma 4.0 market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

North America accounted for large share of the global market in 2021 due to leading role of the U.S. pharmaceutical industry. Other factors driving the market in the region are reduced taxes and lowered drug prices, and advancements in technology & research. Canada is a major market for Pharma 4.0 due to presence of large number of companies in the Ontario region.

The pharmaceutical industry in Europe took the first major step toward digitalization at the beginning of 2019 as the Falsified Medicines Directive (FMD) induced the industry to embrace technological advancements.

Asia Pacific is the second largest pharmaceutical market, after North America, and the region is adopting technological advancements as per Pharma 4.0.

Major Players Operating in Pharma 4.0 Market are listed below:

  • Abbott Laboratories
  • GE Healthcare
  • Boston Scientific
  • Koninklijke Philips NV
  • Pfizer
  • Medtronic plc
  • Johnson & Johnson
  • Vertex
  • Glatt GmbH
  • GlaxoSmithKline
  • Others

Global Pharma 4.0 Market Research Scope

Global Pharma 4.0 Market, by Design

  • Digital Maturity
  • Data Integrity
  • Others

Global Pharma 4.0 Market, by Technology

  • Big Data Analytics
  • Cloud Computing & Automation
  • Cyber Physical Systems
  • Others

Global Pharma 4.0 Market by End-user

  • Hospitals/Clinics
  • Ambulatory Surgical Centers
  • Others

Global Pharma 4.0 Market, by Region

  • North America
    • U S
    • Canada
  • Europe
    • Germany
    • Italy
    • U.K.
    • Spain
    • France
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Interested in this report?
Get a FREE Brochure now!

Request Brochure

*Get Brochure (PDF) sent to your email within minutes

N/A

Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.

807

Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved